RSSS in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with RSSS today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Research Solutions serves researchers at companies, universities and government organizations, as well as individuals who need scientific, technical and medical literature. Scite.ai and Resolute.ai help them search articles and other research data. Article Galaxy and Article Galaxy Scholar help organizations obtain articles using their existing subscriptions and article collections or by purchasing access, while managing spending and usage.
Article transactions bring in most of the revenue: customers pay for sourcing and electronic delivery, along with copyright fees for permitted use. Customers also pay subscriptions for premium software features, generally through annual or multi-year agreements for organizations and annual or monthly plans for individuals.
The business depends on publishers supplying content and granting rights to distribute and reuse it. A small group of publishers accounts for most content costs, and their nonexclusive agreements allow them to supply competitors too. Publisher permissions also limit what the software can show: Scite.ai displays full-text snippets only where the necessary rights have been granted.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Research Solutions’ results hinge on research-platform adoption and demand for paid articles, with privately held Copyright Clearance Center an important article-delivery rival missing from this list.
Research Solutions depends on RELX’s Elsevier for scientific articles it distributes, while Elsevier also competes for the same corporate and academic researchers by selling literature-search and research tools.
John Wiley & Sons publishes scientific journals that Research Solutions distributes, so both depend on researchers paying for scholarly content. Wiley’s Research Publishing business is the part to watch for demand tied to Research Solutions’ per-article sales and rentals.
RESEARCH SOLUTIONS INC earningsThis company
Research Solutions’ report will show whether institutions’ spending on research-platform subscriptions can offset researchers ordering fewer individual articles.
Read platform revenue alongside transaction revenue. Platform growth with article orders no longer falling would show that institutional deployments and cross-selling are building subscriptions while article demand holds up. Slower platform growth alongside continued declines in article orders would show subscriptions are not offsetting weaker per-article sales, leaving Research Solutions’ revenue exposed to softer demand for research content.
John Wiley & Sons, Inc. earningsWLY
John Wiley & Sons’ report will show how demand for scholarly content is changing, a signal for the demand Research Solutions faces in selling and renting articles individually.
Focus on demand in John Wiley & Sons’ Research Publishing business, not its overall results as a proxy for Research Solutions. Resilient research-publishing demand would indicate researchers are still paying for scholarly content, a supportive backdrop for Research Solutions’ individual-article sales and rentals. Weaker demand would point to continued pressure on that transaction business, but Wiley’s report alone cannot confirm Research Solutions’ own order trend.